Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Comparing compliance patterns between randomized treatments.

Vrijens B, Goetghebeur E.

Control Clin Trials. 1997 Jun;18(3):187-203.

PMID:
9204220
2.

Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring.

Leenen FH, Wilson TW, Bolli P, Larochelle P, Myers M, Handa SP, Boileau G, Tanner J.

Can J Cardiol. 1997 Oct;13(10):914-20. Review.

PMID:
9374947
3.

The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.

Thomas GN, Chan P, Tomlinson B.

Drugs Aging. 2006;23(2):131-55. Review.

PMID:
16536636
4.

Compliance, electronic monitoring and antihypertensive drugs.

Mallion JM, Baguet JP, Siche JP, Tremel F, de Gaudemaris R.

J Hypertens Suppl. 1998 Jan;16(1):S75-9. Review.

PMID:
9534102
5.
6.

Methods to improve medication adherence in patients with hypertension: current status and future directions.

Krousel-Wood M, Hyre A, Muntner P, Morisky D.

Curr Opin Cardiol. 2005 Jul;20(4):296-300. Review.

PMID:
15956826
7.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
8.
9.

Multi-compartment medication devices and patient compliance.

McGraw C.

Br J Community Nurs. 2004 Jul;9(7):285-90. Review.

PMID:
15284670
10.

Using fixed-dose combination therapies to achieve blood pressure goals.

Chrysant SG.

Clin Drug Investig. 2008;28(11):713-34. Review.

PMID:
18840014
11.

Evaluation of once-daily antihypertensive therapy.

Myers MG.

Heart Dis. 2000 Mar-Apr;2(2):S7-12. Review.

PMID:
11728257
12.

Combination drug treatment of hypertension: have we come full circle?

Taylor AA.

Curr Cardiol Rep. 2004 Nov;6(6):421-6. Review.

PMID:
15485601
13.

Dispelling the myth of "aggressive" antihypertensive therapy.

Ofili EO.

J Clin Hypertens (Greenwich). 2006 Jan;8(1 Suppl 1):4-11. Review.

14.

Facts and fiction of poor compliance as a cause of inadequate blood pressure control: a systematic review.

Wetzels GE, Nelemans P, Schouten JS, Prins MH.

J Hypertens. 2004 Oct;22(10):1849-55. Review.

PMID:
15361751
15.
16.
17.

Twenty-four-hour ambulatory blood pressure evaluation of antihypertensive agents.

Zanchetti A.

J Hypertens Suppl. 1997 Dec;15(7):S21-5. Review.

PMID:
9532517
18.

Monitoring compliance in resistant hypertension: an important step in patient management.

Burnier M, Santschi V, Favrat B, Brunner HR.

J Hypertens Suppl. 2003 May;21(2):S37-42. Review.

PMID:
12929906
19.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
20.

[Compliance to therapy -- its importance in research and clinical practice].

Boaventura I, Coelho R, Rocha-Gonçalves F.

Rev Port Cardiol. 1994 Sep;13(9):677-83, 640. Review. Portuguese.

PMID:
7818942
Items per page

Supplemental Content

Write to the Help Desk